Navigation Links
Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission
Date:7/30/2014

of Regeneron to manufacture and manage supply chains for multiple products and product candidates; coverage and reimbursement determinations by third-party payers, including Medicare and Medicaid; unanticipated expenses; the costs of developing, producing, and selling products; the ability of Regeneron to meet any of its sales or other financial projections or guidance and changes to the assumptions underlying those projections or guidance; the potential for any license or collaboration agreement, including Regeneron's agreements with Sanofi and Bayer HealthCare LLC, to be cancelled or terminated without any further product success; and risks associated with intellectual property of other parties and pending or future litigation relating thereto.  A more complete description of these and other material risks can be found in Regeneron's filings with the United States Securities and Exchange Commission, including its Form 10-K for the year ended December 31, 2013 and its Form 10-Q for the quarter ended March 31, 2014.  The reader is cautioned not to rely on any forward-looking statements made by Regeneron. Regeneron does not undertake any obligation to update publicly any forward-looking statement, including without limitation any financial projection or guidance, whether as a result of new information, future events, or otherwise. Contacts Sanofi:Media Relations

Investor Relations Jack Cox

Sebastien MartelTel: +33 (0) 1 53 77 94 74

Tel: +33 (0)1 53 77 45 45Mobile: +33 (0) 6 78 52 05 36

E-mail: IR@sanofi.com E-mail: Jack.Cox@sanofi.com <
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Regeneron to Report Second Quarter 2014 Financial and Operating Results and Host Conference Call and Webcast on August 5, 2014
2. Regenerons Chief Executive Officer and Chief Scientific Officer named "Management Team of the Year" by Scrip Intelligence
3. Regeneron Named Top Employer in the Global Biopharmaceutical Industry for the Second Year in a Row
4. After 18 Months On the U.S. Market, Regenerons Eylea Captures One-Fifth of First-Line Intravitreal Pharmacotherapy Share Among Wet Age-Related Macular Degeneration (AMD) Patients
5. Zacks Investment Ideas feature highlights: Market Vectors Biotech ETF, iShares Nasdaq Biotechnology ETF, Regeneron, Celgene and First Trust Amex Biotechnology Index Fund
6. Regeneron Reports First Quarter 2013 Financial and Operating Results
7. Regeneron Pharmaceuticals’ Industrial Operations & Product Supply Site Receives International Recognition for Operational Excellence
8. Sanofi and Regeneron Launch Comprehensive Phase 3 Clinical Program With LDL Cholesterol-Lowering PCSK9 Antibody
9. Sanofi and Regeneron Announce Publication of Positive Phase 2 Results for Lipid-Lowering PCSK9 Antibody in The Lancet
10. Regeneron Announces March 2012 Investor Conference Presentations
11. Regeneron Announces Presentation at the Leerink Swann 2012 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... In an article published and posted online today, senior ... the clinical aspects of diseases caused by 5 major ... "Clinical Management of Potential Bioterrorism-Related Conditions," was published and ... New England Journal of Medicine . ... Inglesby—review the clinical management of conditions resulting from exposure ...
(Date:3/4/2015)... 2015 USDM Life Sciences , ... sciences industry, hired David Blewitt as Vice ... Compliance Services and Solutions at USDM Life Sciences , ... while maintaining compliance with government regulations worldwide. , ... accomplished life sciences regulatory and IS compliance professional with ...
(Date:3/4/2015)... CALGARY , March 4, 2015 /CNW/ ... that it has completed a collaborative research ... quantitative analytics.  Using Fast Collective Evolution Technology ... dataset including all measurements obtained from each ... Company,s Phase 2 clinical trials ASSERT, SUSTAIN ...
(Date:3/4/2015)... CITY, Calif. , March 4, 2015 /PRNewswire/ ... ), a specialty pharmaceutical company focused on the ... treatment of acute and breakthrough pain, today announced ... 2014 financial results after market close on Monday, ... investment-community conference call at 4:30 p.m. Eastern Time ...
Breaking Biology Technology:Latest Clinical Information On Bioterrorism Threats 2USDM Life Sciences Names David Blewitt VP of Cloud Compliance for Regulated Life Sciences 2USDM Life Sciences Names David Blewitt VP of Cloud Compliance for Regulated Life Sciences 3Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program 2Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program 3Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program 4AcelRx Pharmaceuticals to Hold Annual 2014 Financial Results Conference Call and Webcast on Monday, March 9th, 2015 2AcelRx Pharmaceuticals to Hold Annual 2014 Financial Results Conference Call and Webcast on Monday, March 9th, 2015 3
... annual review date is approaching and you're really feeling like ... know you have to have a great argument for your ... You also know that dollars are tight and your boss ... from other employees) to ignore or discount most pay-me-more arguments. ...
... institute on Monday in Milwaukee. Milwaukee ... southeastern Wisconsin is the goal behind the formation of ... a $1 million grant from the University of ... Health Technologies is intended to foster more cooperation between ...
... Four separate but ultimately connected events help to explain ... , Speaking to business leaders in Milwaukee, Hewlett-Packard ... has made it difficult for companies to stand out ... such as distance, scale and working capital are no ...
Cached Biology Technology:Want a raise? Ten best midwest tech salary-increase pitches 2Want a raise? Ten best midwest tech salary-increase pitches 3Want a raise? Ten best midwest tech salary-increase pitches 4Want a raise? Ten best midwest tech salary-increase pitches 5New biomedical institute aims to unite business and academia in SE Wisconsin 2New biomedical institute aims to unite business and academia in SE Wisconsin 3New biomedical institute aims to unite business and academia in SE Wisconsin 4In an increasingly 'flat' world, Wisconsin must adapt to compete 2In an increasingly 'flat' world, Wisconsin must adapt to compete 3
(Date:2/5/2015)... Jan. 30, 2015  It is gratifying to see ... potential for genomic science as a means to better ... and treatment.  I was honored to participate in today,s ... medicine program. Since the 1980s my ... genomics—from the first sequenced genome of a free living ...
(Date:1/22/2015)... Markets ( http://www.researchandmarkets.com/research/4trb7t/biometrics_a ) has announced the addition ... report to their offering. , The primary ... is who she/he is claiming to be, and for this ... physical characteristics, such as fingerprint, hand or palm print, iris, ...
(Date:1/22/2015)... , Jan. 13, 2015 /PRNewswire/ - Today, FindBiometrics, the leading ... the launch of its new website design. "When ... its infancy", says Peter O,Neill , founder and CEO ... the industry needs involvement from the key players on a ...
Breaking Biology News(10 mins):J. Craig Venter, Ph.D., Co-Founder and CEO, Human Longevity, Inc. (HLI) Participates in White House Precision Medicine Event 2Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2
... A Purdue University scientist has discovered a key process in ... Xiaoqi Liu, an assistant professor of biochemistry, found that ... during cell growth, as well as a shortage of the ... laboratory showed that the Plk1 molecule indirectly attacks p53 in ...
... German . , Kinarm Ko and Hans ... in Mnster have succeeded for the first time in culturing ... mice and converting these cells into pluripotent stem cells without ... the capacity to generate all types of body tissue. The ...
... Jay K. Kolls, MD, Professor and Chairman of Genetics at ... been awarded $1.8 million over five years by the National ... Health to study whether antibodies that recognize carbohydrate (sugars) and ... Pneumocystis carinii pneumonia (PCP) can be used to prevent ...
Cached Biology News:Protein can help cells or cause cancer, Purdue researcher finds 2Playing it safe 2Playing it safe 3
1 unit is sufficient for 1 caspase activity assay....
RABBIT ANTI WARFARIN...
Request Info...
... Gelzyme is an agarose-digesting enzyme isolated ... simple carbohydrate bonds in agarose producing ... gel. The remaining carbohydrate molecules will ... DNA isolated with Gelzyme enzyme can ...
Biology Products: